Compounds > levodopa
Page last updated: 2024-08-17

levodopa and lactic acid

levodopa has been researched along with lactic acid in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (7.69)18.2507
2000's4 (30.77)29.6817
2010's7 (53.85)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Anderson, JJ; Bravi, D; Chase, TN; Dagani, F; Davis, TL; Ferrari, R; Gillespie, M1
Dewar, KM; Stravynski, A1
Bendsoe, N; Ronquist, G1
Gille, G; Radad, K; Rausch, WD; Reichmann, H1
Artuch, R; Briones, P; Carrilho, I; Duarte, S; Garcia-Cazorla, A; Garesse, R; Montoya, J; Nascimento, A; Ormazabal, A; Pineda, M; Sala-Castellvi, P; Serrano, M1
D'Aurizio, E; Di Stefano, A; Hennink, WE; Siepmann, F; Siepmann, J; Sozio, P; van Nostrum, CF; van Steenbergen, MJ1
Brunetti, L; Cerasa, LS; Chiavaroli, A; D'Aurizio, E; Di Stefano, A; Hennink, WE; Kok, RJ; Orlando, G; Sozio, P; Vacca, M1
Alany, RG; Chuang, V; Wen, J; Zhou, YZ1
Chen, Y; Hong, X; Liu, Z; Song, L; Wu, N; Yang, X; Yuan, W1
Che, JY; Gan, J; Liu, ZG; Song, L; Wang, WW; Xie, CL; Yuan, ML; Yuan, WE; Zhang, SF1
Chang, CC; Cheng, W; Mapanao, R1
Chen, Q; Liu, W; Ma, X; Qian, Z; Ran, Z; Shang, Z; Wang, X; Yang, Y; Zhang, L1

Reviews

1 review(s) available for levodopa and lactic acid

ArticleYear
The quest for biological correlates of social phobia: an interim assessment.
    Acta psychiatrica Scandinavica, 2001, Volume: 103, Issue:4

    Topics: Adrenergic alpha-Agonists; Adult; Animals; Benzodiazepines; Brain; Carbon Dioxide; Clonidine; Epinephrine; Female; Fenfluramine; Gastrointestinal Agents; Human Growth Hormone; Humans; Hydrocortisone; Lactic Acid; Levodopa; Magnetic Resonance Spectroscopy; Male; Monoamine Oxidase Inhibitors; Pentagastrin; Phobic Disorders; Prolactin; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed, Single-Photon

2001

Other Studies

12 other study(ies) available for levodopa and lactic acid

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:3

    Topics: Age Factors; Blood Glucose; Blood Platelets; Carbidopa; Drug Therapy, Combination; Energy Metabolism; Female; Humans; Lactates; Lactic Acid; Levodopa; Lisuride; Male; Middle Aged; Mitochondria; Oxygen Consumption; Parkinson Disease; Receptors, Dopamine; Selegiline

1992
Inhibition of the L-dopa transport system in human epidermal Langerhans cells by omeprazole and its analogues.
    Amino acids, 2004, Volume: 26, Issue:1

    Topics: Adenosine Triphosphatases; Biological Transport, Active; Cells, Cultured; Cytoplasmic Vesicles; Enzyme Inhibitors; Epidermal Cells; Gastric Mucosa; Humans; Hydrogen; Lactic Acid; Langerhans Cells; Levodopa; Omeprazole; Potassium

2004
Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture.
    Journal of neural transmission (Vienna, Austria : 1996), 2006, Volume: 113, Issue:9

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Carbidopa; Cell Count; Cells, Cultured; Dihydroergocryptine; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Synergism; Female; Lactic Acid; Levodopa; Mice; Neuroglia; Neurons; Pregnancy; Sulpiride; Tyrosine 3-Monooxygenase

2006
Mitochondrial diseases mimicking neurotransmitter defects.
    Mitochondrion, 2008, Volume: 8, Issue:3

    Topics: Alanine; Brain; Child, Preschool; Consanguinity; Diagnosis, Differential; Dopamine Agents; Dystonia; Electron Transport Complex I; Electron Transport Complex II; Electron Transport Complex III; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant; Infant, Newborn; Lactic Acid; Levodopa; Male; Mitochondrial Diseases; Neurotransmitter Agents; Pterins; Radiography; Treatment Outcome

2008
Preparation and characterization of poly(lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug.
    International journal of pharmaceutics, 2011, May-16, Volume: 409, Issue:1-2

    Topics: Antiparkinson Agents; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Stability; Emulsions; Half-Life; Lactic Acid; Levodopa; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prodrugs; Solvents; Thioctic Acid

2011
Biodegradable microspheres loaded with an anti-Parkinson prodrug: an in vivo pharmacokinetic study.
    Molecular pharmaceutics, 2011, Dec-05, Volume: 8, Issue:6

    Topics: Absorbable Implants; Animals; Antiparkinson Agents; Delayed-Action Preparations; Lactic Acid; Levodopa; Male; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prodrugs; Rats; Rats, Wistar; Thioctic Acid

2011
Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design.
    Drug development and industrial pharmacy, 2013, Volume: 39, Issue:2

    Topics: Biocompatible Materials; Drug Compounding; Lactic Acid; Levodopa; Models, Chemical; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polyvinyl Alcohol; Solvents

2013
Levodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats.
    Drug design, development and therapy, 2012, Volume: 6

    Topics: Animals; Antiparkinson Agents; Benserazide; Blotting, Western; Delayed-Action Preparations; Disease Models, Animal; Down-Regulation; Drug Carriers; Drug Combinations; Dyskinesia, Drug-Induced; Female; Lactic Acid; Levodopa; Microspheres; Oxidopamine; Parkinsonian Disorders; Phosphorylation; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, AMPA

2012
Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats.
    Scientific reports, 2014, Dec-16, Volume: 4

    Topics: Adrenergic Agents; Animals; Benserazide; Blotting, Western; Corpus Striatum; Cyclic AMP-Dependent Protein Kinases; Dopamine Agents; Drug Combinations; Dyskinesias; Female; Fluorescent Antibody Technique; Lactic Acid; Levodopa; Microspheres; Neurons; Oxidopamine; Parkinson Disease; Phosphoproteins; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; tau Proteins; Transcription Factors

2014
The upregulation of immune responses in tyrosine hydroxylase (TH) silenced Litopenaeus vannamei.
    Developmental and comparative immunology, 2017, Volume: 67

    Topics: Animals; Arthropod Proteins; Cells, Cultured; Dopamine beta-Hydroxylase; Down-Regulation; Gene Silencing; Glucose; Granulocytes; Hemolymph; Immunity, Innate; Invertebrate Hormones; Lactic Acid; Levodopa; Nerve Tissue Proteins; Penaeidae; RNA, Double-Stranded; Tyrosine 3-Monooxygenase; Vibrio alginolyticus; Vibrio Infections

2017
Enzymatic colorimetric method for turn-on determination of l-lactic acid through indicator displacement assay.
    Journal of bioscience and bioengineering, 2023, Volume: 136, Issue:3

    Topics: Carboxylic Acids; Colorimetry; Lactic Acid; Levodopa; Monophenol Monooxygenase

2023